• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)与常见免疫显性区域或许可以解释疟疾流行带中新冠病毒疾病(COVID-19)发病率较低的现象。

SARS-CoV-2 and common immunodominant regions may explain low COVID-19 incidence in the malaria-endemic belt.

作者信息

Iesa M A M, Osman M E M, Hassan M A, Dirar A I A, Abuzeid N, Mancuso J J, Pandey R, Mohammed A A, Borad M J, Babiker H M, Konozy E H E

机构信息

Department of Physiology, Al Qunfudah Medical College, Umm Al Qura University, Mecca, Saudi Arabia.

Department of Zoology, Faculty of Science, University of Khartoum, Khartoum, Sudan.

出版信息

New Microbes New Infect. 2020 Nov;38:100817. doi: 10.1016/j.nmni.2020.100817. Epub 2020 Nov 19.

DOI:10.1016/j.nmni.2020.100817
PMID:33230417
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7674012/
Abstract

Coronavirus disease 2019 (COVID-19) has caused significant morbidity and mortality and new cases are on the rise globally, yet malaria-endemic areas report statistically significant lower incidences. We identified potential shared targets for an immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by immune determinants' shared identities with using the Immune Epitope Database and Analysis Resource Immune 9.0 browser tool. Probable cross-reactivity is suggested through HLA-A∗02:01 and subsequent CD8 T-cell activation. The apparent immunodominant epitope conservation between SARS-CoV-2 (N and open reading frame (ORF) 1ab) and thrombospondin-related anonymous protein (TRAP) may underlie the low COVID-19 incidence in the malaria-endemic zone by providing immunity against virus infection to those previously infected with . Additionally, we hypothesize that the shared epitopes which lie within antigens that aid in the establishment of the erythrocyte invasion may be an alternative route for SARS-CoV-2 via the erythrocyte CD147 receptor, although this remains to be proven.

摘要

2019冠状病毒病(COVID-19)已导致大量发病和死亡,全球新病例数正在上升,但疟疾流行地区报告的发病率在统计学上显著较低。我们通过使用免疫表位数据库和分析资源免疫9.0浏览器工具,根据免疫决定因素的共享身份,确定了针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)免疫反应的潜在共同靶点。通过HLA-A∗02:01和随后的CD8 T细胞激活提示可能存在交叉反应性。SARS-CoV-2(N和开放阅读框(ORF)1ab)与血小板反应蛋白相关无名蛋白(TRAP)之间明显的免疫显性表位保守性,可能通过为先前感染过[某种病原体]的人提供抗病毒感染免疫力,从而成为疟疾流行区COVID-19发病率低的原因。此外,我们假设,位于有助于疟原虫建立红细胞入侵的抗原内的共享表位,可能是SARS-CoV-2通过红细胞CD147受体入侵的另一条途径,尽管这仍有待证实。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f56d/7749403/1cde9240eb40/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f56d/7749403/0aae4805e6a2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f56d/7749403/1cde9240eb40/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f56d/7749403/0aae4805e6a2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f56d/7749403/1cde9240eb40/gr2.jpg

相似文献

1
SARS-CoV-2 and common immunodominant regions may explain low COVID-19 incidence in the malaria-endemic belt.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)与常见免疫显性区域或许可以解释疟疾流行带中新冠病毒疾病(COVID-19)发病率较低的现象。
New Microbes New Infect. 2020 Nov;38:100817. doi: 10.1016/j.nmni.2020.100817. Epub 2020 Nov 19.
2
Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to Acute Malaria: LAG-3 and TIM-3 Correlate With T Cell Activation and Course of Disease.分析 COVID-19 感染与急性疟疾中抑制性受体的表达:LAG-3 和 TIM-3 与 T 细胞激活和疾病过程相关。
Front Immunol. 2020 Aug 26;11:1870. doi: 10.3389/fimmu.2020.01870. eCollection 2020.
3
Limited Recognition of Highly Conserved Regions of SARS-CoV-2.有限识别 SARS-CoV-2 的高度保守区域。
Microbiol Spectr. 2022 Feb 23;10(1):e0278021. doi: 10.1128/spectrum.02780-21.
4
Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach.揭示 SARS-CoV-2 未注释的 ORF 抗原中存在的有效表位,为基于表位的多价疫苗设计提供免疫信息学方法。
Front Immunol. 2021 Aug 23;12:692937. doi: 10.3389/fimmu.2021.692937. eCollection 2021.
5
Insights into and SARS-CoV-2 co-infection driven neurological manifestations.对流感病毒和新冠病毒共同感染引发的神经学表现的见解。
Biosaf Health. 2021 Aug;3(4):230-234. doi: 10.1016/j.bsheal.2021.04.001. Epub 2021 Apr 30.
6
Exploring SARS-CoV-2 and coinfection in human erythrocytes.探索 SARS-CoV-2 与人类红细胞的合并感染。
Front Immunol. 2023 Mar 13;14:1120298. doi: 10.3389/fimmu.2023.1120298. eCollection 2023.
7
Structural basis of biased T cell receptor recognition of an immunodominant HLA-A2 epitope of the SARS-CoV-2 spike protein.SARS-CoV-2 刺突蛋白免疫优势 HLA-A2 表位的偏倚性 T 细胞受体识别的结构基础。
J Biol Chem. 2021 Sep;297(3):101065. doi: 10.1016/j.jbc.2021.101065. Epub 2021 Aug 10.
8
CD8 T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses.针对 SARS-CoV-2 核衣壳表位的免疫优势 CD8 T 细胞与选择性季节性冠状病毒发生交叉反应。
Immunity. 2021 May 11;54(5):1055-1065.e5. doi: 10.1016/j.immuni.2021.04.006. Epub 2021 Apr 13.
9
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
10
Unbiased Screens Show CD8 T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein.非偏向性筛选表明 COVID-19 患者的 CD8 T 细胞识别 SARS-CoV-2 中的共享表位,这些表位主要位于 Spike 蛋白之外。
Immunity. 2020 Nov 17;53(5):1095-1107.e3. doi: 10.1016/j.immuni.2020.10.006. Epub 2020 Oct 20.

引用本文的文献

1
Explaining international differences in excess mortality due to Covid-19.解释新冠疫情导致的超额死亡率的国际差异。
Sci Rep. 2025 Apr 22;15(1):13879. doi: 10.1038/s41598-025-92403-z.
2
COVID-19 inflammatory signature in a Mozambican cohort: unchanged red blood series and reduced levels of IL-6 and other proinflammatory cytokines.莫桑比克队列中的 COVID-19 炎症特征:红细胞系列不变,IL-6 和其他促炎细胞因子水平降低。
BMC Infect Dis. 2024 Nov 11;24(1):1279. doi: 10.1186/s12879-024-10132-6.
3
Humoral Immunity Profiling to Pandemic and Bat-Derived Coronavirus Variants: A Geographical Comparison.

本文引用的文献

1
Metadichol®: A Novel Nanolipid Formulation That Inhibits SARS-CoV-2 and a Multitude of Pathological Viruses In Vitro.美达多醇®:一种新型纳米脂质体制剂,可在体外抑制 SARS-CoV-2 及多种病理性病毒。
Biomed Res Int. 2022 Jan 15;2022:1558860. doi: 10.1155/2022/1558860. eCollection 2022.
2
A systematic review of SARS-CoV-2 vaccine candidates.SARS-CoV-2 疫苗候选物的系统评价。
Signal Transduct Target Ther. 2020 Oct 13;5(1):237. doi: 10.1038/s41392-020-00352-y.
3
Individuals with a Rh-positive but not Rh-negative blood group are more vulnerable to SARS-CoV-2 infection: demographics and trend study on COVID-19 cases in Sudan.
针对大流行和蝙蝠源性冠状病毒变种的体液免疫分析:地域比较
Adv Sci (Weinh). 2025 Jan;12(1):e2403503. doi: 10.1002/advs.202403503. Epub 2024 Oct 29.
4
Impact of latent toxoplasmosis on pneumonic and non-pneumonic COVID-19 patients with estimation of relevant oxidative stress biomarkers.潜伏性弓形体感染对有或无肺部表现的 COVID-19 患者的影响,并评估相关氧化应激生物标志物。
Folia Parasitol (Praha). 2024 Apr 4;71:2024.008. doi: 10.14411/fp.2024.008.
5
Cutaneous Leishmaniasis Hampers COVID-19: A Controlled Cross-Sectional Study in High-Burden Endemic Areas of Iran.皮肤利什曼病阻碍新冠病毒感染:伊朗高负担流行地区的一项对照横断面研究
J Epidemiol Glob Health. 2024 Mar;14(1):142-153. doi: 10.1007/s44197-023-00179-0. Epub 2024 Jan 8.
6
Clinical profile and Predictors of Outcomes of Hospitalized Patients with Laboratory-Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 in Nigeria: A Retrospective Analysis of 13 High Burden States in Nigeria.尼日利亚实验室确诊的严重急性呼吸综合征冠状病毒2型住院患者的临床特征及预后预测因素:尼日利亚13个高负担州的回顾性分析
Niger Med J. 2023 Mar-Apr;64(2):205-219. Epub 2023 May 11.
7
Climate and COVID-19 transmission: a cross-sectional study in Africa.气候与 COVID-19 传播:非洲的一项横断面研究。
Sci Rep. 2023 Oct 31;13(1):18702. doi: 10.1038/s41598-023-46007-0.
8
Population-based assessment of the burden of COVID-19 infection in African countries: a first-year report card and public health implications.非洲国家基于人群的新冠病毒感染负担评估:首年成绩单及对公共卫生的影响
Ther Adv Infect Dis. 2023 Sep 28;10:20499361231202116. doi: 10.1177/20499361231202116. eCollection 2023 Jan-Dec.
9
Exploring SARS-CoV-2 and coinfection in human erythrocytes.探索 SARS-CoV-2 与人类红细胞的合并感染。
Front Immunol. 2023 Mar 13;14:1120298. doi: 10.3389/fimmu.2023.1120298. eCollection 2023.
10
Main modulators of COVID-19 epidemic in sub-Saharan Africa.撒哈拉以南非洲地区新冠疫情的主要调节因素。
Heliyon. 2023 Jan;9(1):e12727. doi: 10.1016/j.heliyon.2022.e12727. Epub 2022 Dec 29.
具有Rh阳性而非Rh阴性血型的个体更容易感染新冠病毒:苏丹新冠肺炎病例的人口统计学和趋势研究。
New Microbes New Infect. 2020 Nov;38:100763. doi: 10.1016/j.nmni.2020.100763. Epub 2020 Sep 22.
4
What could explain the late emergence of COVID-19 in Africa?如何解释新冠病毒病在非洲出现较晚的情况?
New Microbes New Infect. 2020 Nov;38:100760. doi: 10.1016/j.nmni.2020.100760. Epub 2020 Sep 22.
5
Multiple drivers of the COVID-19 spread: The roles of climate, international mobility, and region-specific conditions.COVID-19 传播的多重驱动因素:气候、国际流动性和特定地区条件的作用。
PLoS One. 2020 Sep 23;15(9):e0239385. doi: 10.1371/journal.pone.0239385. eCollection 2020.
6
COVID-19 in Africa: Dampening the storm?非洲的新冠疫情:平息风暴?
Science. 2020 Aug 7;369(6504):624-626. doi: 10.1126/science.abd3902.
7
Plasmodium falciparum Infection May Protect a Population from Severe Acute Respiratory Syndrome Coronavirus 2 Infection.恶性疟原虫感染可能使人群免受严重急性呼吸综合征冠状病毒2感染。
J Infect Dis. 2020 Oct 1;222(9):1570-1571. doi: 10.1093/infdis/jiaa455.
8
Coronavirus disease 2019 (COVID 19) and Malaria: Have anti glycoprotein antibodies a role?2019冠状病毒病(COVID - 19)与疟疾:抗糖蛋白抗体起作用吗?
Med Hypotheses. 2020 Oct;143:110036. doi: 10.1016/j.mehy.2020.110036. Epub 2020 Jun 25.
9
COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. A narrative review.新型冠状病毒肺炎:超越炎症的血红蛋白、铁与缺氧。一篇综述。
Clin Pract. 2020 May 28;10(2):1271. doi: 10.4081/cp.2020.1271. eCollection 2020 May 19.
10
Why is There Low Morbidity and Mortality of COVID-19 in Africa?为什么非洲的 COVID-19 发病率和死亡率低?
Am J Trop Med Hyg. 2020 Aug;103(2):564-569. doi: 10.4269/ajtmh.20-0474. Epub 2020 Jun 1.